CCI nod for amalgamation of SRL, Appcure & Vindhya Organics (See 'Corp Brief') CCI okays acquisition of AI Lenarco Midco Ltd. by Majesty II Pte. Ltd (See 'Corp Brief') SARFAESI Act - While exercising powers under Cr.P.C, Courts can not intervene at stage of investigation/proceedings: HC (See 'Legal Desk') CCI approves combination of Agro Tech Foods, BEL, DMPL India & Del Monte Foods (See 'Corp Brief') India's Renewable Energy sector is leading global force: Joshi (See 'Corp Brief') A&C - Any error in order passed by court in Arbitration Proceedings, can be corrected u/s 152 & 153 of CPC, provided prejudice is not caused to other party: HC (See 'Legal Desk') TRAI inaugurates SATRC Workshop on Spectrum (See 'Corp Brief') Trade Marks Act - As respondent abandoned display subject mark, it indicate he is no longer interested in mark: HC (See 'Legal Desk') UIDAI conducts stakeholders meet with BFSI, Fintech and Telcos (See 'Corp Brief') MoS inaugurates International Congress on Glass (See 'Corp Brief') Misc - Cheque issued after retirement of director of company would not trigger his liability u/s 141 of Negotiable Instrument Act: SC (See 'Legal Desk') Minister visits ICAT, Commends India's Automotive Innovation (See 'Corp Brief') Minister addresses SIAM's Conference on Sustainable Circularity (See 'Corp Brief') A&C - Substantive objections concerning validity & existence of arbitration agreement can be adjudicated by Arbitral Tribunal and not by court u/s 11: HC (See 'Legal Desk') India will emerge as Global Hub for Critical Minerals: Reddy (See 'Corp Brief') ECI to host Conference of Election Management Bodies (See 'Corp Brief') A&C - Court's jurisdiction u/s 34 of Arbitration Act against award passed u/s 18(4) of MSMED Act 2006, is determined by agreement between parties: HC (See 'Legal Desk') Colaba Research Centre of IIG set to digitise archived data sets (See 'Corp Brief') Misc - Disputed question of facts relating to existence of seperate entity as far as holding and subsidiary entities are concerned, cannot be adjudicated in writ jurisdiction: HC (See 'Legal Desk') Mandaviya to inaugurate Seminar on 'Formalization and Social Security Coverage' (See 'Corp Brief') FSSAI rolls out comprehensive measures for Food Safety at Maha Kumbh (See 'Corp Brief') PMLA - Rigors of Section 45 not applicable onto women; bail allowed as claimant neither has criminal antecedents nor are there immediate prospects for trial's conclusion: SC (See 'Legal Desk') ODOP Exhibition displayed in 6000 Square Meters at Mahakumbh (See 'Corp Brief') GSI charts Extensive Roadmap with 1,065 Scientific Programs (See 'Corp Brief') A&C - Invoking writ jurisdiction to challenge arbitral award would circumvent statutory requirement of pre-deposit u/s 19 of MSMED Act, and would amount to defeating legislative intent: HC (See 'Legal Desk') State Governments must promote Rooftop Solar Schemes: Khattar (See 'Corp Brief') Misc - Section 91 of CrPC cannot be invoked by accused at stage of framing of charges: HC (See 'Legal Desk') Mines Ministry opens DMF Exhibition at Sun Temple, Konark (See 'Corp Brief') RTI - Request for soliciting opinions & confirmations about factual situation, are in nature of explanation & opinion, and hence beyond scope of 'information' u/s 2(f) and 'right to information' u/s 2(j) of RTI Act: IBBI (See 'Legal Desk')

Print

CCI nod for amalgamation of SRL, Appcure & Vindhya Organics

Published: Jan 22, 2025

By TIOLCorplaws News Service

NEW DELHI, JAN 22, 2025: THE Competition Commission of India has approved the proposed amalgamation of SRL, Viyash, Symed, Appcure, Vindhya Pharma, Vandana, Vindhya Organics, Geninn and SV Labs with Sequent Scientific Limited.

Sequent Scientific Limited (SSL) is a publicly listed company, having operations globally in the animal healthcare industry. The company offers a comprehensive range of Active Pharmaceutical Ingredients (API s), finished dosage formulations (FDF s), and analytical services to meet the needs of the animal health sector. Sequent Research Limited (SRL) is a wholly owned subsidiary of SSL, which operates as a Contract Research Organization providing analytical services and a wide array of testing to the global pharmaceutical industry.

Viyash Life Sciences Private Limited (Viyash) is a pharmaceutical company and through its subsidiaries is primarily engaged in the development, manufacture and sale of APIs and intermediates for human healthcare in India. Further, it also manufactures FDFs for human healthcare. Symed Labs Limited (Symed), Appcure Labs Private Limited (Appcure), Vindhya Pharma (India) Private Limited (Vindhya Pharma) and  Vandana Life Sciences Private Limited (Vandana) are wholly owned subsidiaries of Viyash and S.V. Labs Private Limited (SV Labs) is a wholly owned step-down subsidiary of Viyash (through Vindhya Pharma)

Geninn Life Sciences Private Limited (Geninn) is a holding company and does not have any operations of its own. It has a wholly owned subsidiary, Vindhya Organics Private Limited (Vindhya Organics) which is primarily engaged in the business of development, manufacture and marketing APIs for human healthcare.

The Proposed Combination involves a series of inter-connected steps carried out for the amalgamation of SRL, Viyash, Symed, Appcure, Vindhya Pharma, Vandana, Vindhya Organics, Geninn and SV Labs with SSL as the ultimate surviving entity (Proposed Combination).

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
taxindiaonline
A Taxongo Website. Copyright © 2016-2022 tiolcorplaws.com All rights reserved.